pcDNA5 FRT TO Myc ArA K162R
(Plasmid
#59805)
-
PurposeAllows the integration of Myc ArA K162R in the genome and Tet-inducible expression
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 59805 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA5/FRT/TO
-
Backbone manufacturerInvitrogen
-
Vector typeMammalian Expression
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameAurora A
-
SpeciesH. sapiens (human)
-
MutationK162R, kinase mutant
-
Entrez GeneAURKA (a.k.a. AIK, ARK1, AURA, BTAK, PPP1R47, STK15, STK6, STK7)
- Promoter hybrid human cytomegalovirus (CMV)/TetO2 promoter
-
Tag
/ Fusion Protein
- Myc (N terminal on insert)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer CMV-F
- 3′ sequencing primer BGH-rev (Common Sequencing Primers)
Resource Information
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA5 FRT TO Myc ArA K162R was a gift from Stephen Taylor (Addgene plasmid # 59805 ; http://n2t.net/addgene:59805 ; RRID:Addgene_59805) -
For your References section:
Validating Aurora B as an anti-cancer drug target. Girdler F, Gascoigne KE, Eyers PA, Hartmuth S, Crafter C, Foote KM, Keen NJ, Taylor SS. J Cell Sci. 2006 Sep 1;119(Pt 17):3664-75. Epub 2006 Aug 15. 10.1242/jcs.03145 PubMed 16912073